A Study Assessing the Efficacy and Safety of SM03 in Patients With Active Rheumatoid Arthritis Receiving MTX
Clinical trial NCT04312815 · UNKNOWN
Trial details
- NCT number
- NCT04312815
- Sponsor
- SinoMab BioScience Ltd
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-28
- Primary completion
- 2021-12-01
- Enrollment
- 510
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.